Therefore, to test the hypothesis, we analyzed the expression of LC3B-II in the hippocampi and found a highly significant increase in its levels in the mice treated with FXN ( Figure 8A ).
← all excerpts
Fluvoxamine maleate alleviates amyloid-beta load and neuroinflammation in 5XFAD mice to ameliorate Alzheimer disease pathology.
1
—
—